Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus

NCT01942668 is registered in ClinicalTrials.gov with TherapeuticsMD as lead sponsor.

NCT NCT01942668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01942668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Lead sponsor
TherapeuticsMD
Phase
Phase 3
Overall status
Completed
Start date
August 5, 2013
Completion date
October 28, 2016
Enrollment
1,845 (actual)
Sites
119

Conditions

As the registry lists them; a condition with its own page is linked.

menopause